[Contrast density and side effect rate in lumbar myelography--a clinical comparison of Meglumin-Iocarmate and Metrizamide]

Z Orthop Ihre Grenzgeb. 1979 Feb;117(1):115-8.
[Article in German]

Abstract

The author reports that side effects were somewhat more frequent after metrizamide than after meglumin-iocarmate, in the course of a comparative study carried out at the reporting hospital from the beginning of 1977, using the water-soluble x-ray contrast media Amipaque (metrizamide) and Dimer X (meglumin-iocarmate).

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Clinical Trials as Topic
  • Female
  • Humans
  • Iothalamate Meglumine / adverse effects*
  • Male
  • Metrizamide / adverse effects*
  • Myelography / adverse effects*
  • Spinal Cord Diseases / diagnostic imaging

Substances

  • Metrizamide
  • Iothalamate Meglumine